Form 8.3 - Aon plc

Form 8.3 - Aon plc

BARCLAYS PLC

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 14 July 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

ORD

 

 

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

625,315

0.28%

1,677,923

0.74%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

240,925

0.11%

0

0.00%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

24,200

0.01%

24,200

0.01%

 

 

 

 

TOTAL:

 

 

 

 

890,440

0.39%

1,702,123

0.75%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

4

230.2800 USD
Purchase

12

230.2750 USD
Purchase

22

229.7400 USD
Purchase

37

230.3072 USD
Purchase

100

230.5600 USD
Purchase

100

229.6950 USD
Purchase

100

230.1000 USD
Purchase

100

229.8400 USD
Purchase

102

230.3850 USD
Purchase

132

230.6209 USD
Purchase

168

230.5840 USD
Purchase

200

230.4350 USD
Purchase

200

230.4825 USD
Purchase

200

231.1675 USD
Purchase

200

231.1925 USD
Purchase

200

231.2200 USD
Purchase

200

229.7050 USD
Purchase

200

230.2450 USD
Purchase

200

230.2850 USD
Purchase

215

230.2144 USD
Purchase

300

231.1900 USD
Purchase

300

230.6266 USD
Purchase

300

230.2166 USD
Purchase

300

230.4100 USD
Purchase

332

230.2539 USD
Purchase

395

230.8844 USD
Purchase

453

230.3099 USD
Purchase

501

230.1550 USD
Purchase

600

229.9900 USD
Purchase

606

230.0609 USD
Purchase

700

230.1952 USD
Purchase

700

230.1285 USD
Purchase

702

231.2000 USD
Purchase

710

229.7928 USD
Purchase

755

229.8158 USD
Purchase

847

229.9624 USD
Purchase

893

230.4024 USD
Purchase

935

230.1164 USD
Purchase

1,131

230.0767 USD
Purchase

1,301

230.3094 USD
Purchase

1,411

229.9426 USD
Purchase

1,855

230.0125 USD
Purchase

2,020

230.6429 USD
Purchase

2,060

230.1891 USD
Purchase

2,119

230.1760 USD
Purchase

3,011

229.9094 USD
Purchase

3,158

230.3768 USD
Purchase

3,798

230.4352 USD
Purchase

4,857

230.1135 USD
Purchase

8,288

230.0287 USD
Purchase

8,410

230.0364 USD
Purchase

9,360

230.2234 USD
Purchase

9,777

230.4300 USD
Purchase

16,469

230.3621 USD
Purchase

37,741

230.1556 USD
Sale

1

230.4900 USD
Sale

14

231.9600 USD
Sale

26

230.0807 USD
Sale

56

230.0950 USD
Sale

100

230.0527 USD
Sale

109

230.2800 USD
Sale

114

230.2984 USD
Sale

200

230.0500 USD
Sale

200

230.0200 USD
Sale

236

230.1619 USD
Sale

308

230.0217 USD
Sale

367

229.9068 USD
Sale

400

230.0700 USD
Sale

453

230.3099 USD
Sale

466

230.3033 USD
Sale

702

231.2000 USD
Sale

718

229.7994 USD
Sale

1,077

230.0938 USD
Sale

1,815

230.3734 USD
Sale

2,435

230.4131 USD
Sale

2,626

230.2944 USD
Sale

5,177

230.4300 USD
Sale

5,821

229.9217 USD
Sale

5,986

230.8294 USD
Sale

6,726

230.0072 USD
Sale

7,608

230.2203 USD
Sale

8,719

230.0949 USD
Sale

18,801

230.3999 USD
Sale

56,194

230.1271 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

15 Jul 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name

Written or

Number of

Exercise

Type Expiry

 

purchased

relevant securities

price

date

 

 

to which the option

 

 

 

or derivative

 

 

 

relates

 

Put Options

Purchased

-1,200

220.0000

American Jul 16, 2021

Call Options

Purchased

1,200

240.0000

American Jul 16, 2021

Call Options

Purchased

23,000

220.0000

American Jul 16, 2021

Put Options

Purchased

-23,000

200.0000

American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings